A new mobile eye clinic has opened in Nursling, aiming to reduce NHS eye waiting times for Hampshire patients. The newly ...

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially ...

Global Oncology Clinical Trial Market Demonstrates Steady Growth Amidst Rising Cancer Incidence and Technological Advancements The global Oncology Clinical Trial Market Size is experiencing consistent ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

The new approach from Brown uses gold nanorods injected into the eye's vitreous humor and incorporated into the retina, to ...

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80.

Age-related macular degeneration begins with weakening of retinal pigment epithelium cells (RPEs), a layer of cells that support the retina's photoreceptors. When degeneration occurs, the affected ...

The FDA has sent Regeneron a complete response letter, rejecting its bid to stretch the administration of high-dose Eylea ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...

ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.